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Many biologists are now routinely seeking to determine the three-dimensional
structures of their proteins of choice, illustrating the importance of this know-
ledge, but also of the simplification and streamlining of structure-determination
processes. Despite the fact that most software packages offer simple pipelines,
for the non-expert navigating the outputs and understanding the key aspects can
be daunting. Here, the structure determination of the type IV pili (TFP) protein
PilA1 from Clostridioides difficile is used to illustrate the different steps
involved, the key decision criteria and important considerations when using the
most common pipelines and software. Molecular-replacement pipelines within
CCP4i2 are presented to illustrate the more commonly used processes. Previous
knowledge of the biology and structure of TFP pilins, particularly the presence
of a long, N-terminal -helix required for pilus formation, allowed informed
decisions to be made during the structure-determination strategy. The PilA1
structure was finally successfully determined using ARCIMBOLDO and the ab
initio MR strategy used is described.
1. Introduction
Once complete diffraction data at an appropriate resolution
(usually at least around 3–3.5 A˚) have been recorded from a
protein crystal sample, the next challenge is to solve the phase
problem (Taylor, 2003). Phases are required to calculate an
electron-density map, from which a model of the structure is
built. These are missing from diffraction data experiments
and can be experimentally derived using techniques such as
single/multiple anomalous dispersion (SAD/MAD) or single/
multiple isomorphous replacement (SIRAS/MIRAS) (Taylor,
2010; Wang et al., 2014). Alternatively, phases can be calcu-
lated using similar structures that have already been deter-
mined, which is known as molecular replacement (MR). Here,
we review an outline of a number of different strategies (Fig. 1)
starting with a single sweep of X-ray diffraction data to
calculate an electron-density map using molecular replace-
ment. We use the structure determination of the major pilin in
type IV pili (TFP), PilA1, from Clostridioides difficile as a
working example.
Molecular replacement can be used to determine phases for
new structures using diffraction data of reasonable quality (R
factors below 50%). While high-resolution data are prefer-
able, it is the low-resolution information that is most impor-
tant for molecular replacement, and there are a number of
examples in the PDB of structures phased by molecular
replacement where the data do not extend beyond 10 A˚
resolution (Evans & McCoy, 2008). MR does not require
considerations such as the pre-soaking of crystals with heavy
atoms or production, purification and crystallization that
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incorporates an anomalously scattering atom such as sele-
nium, or determining the specific X-ray wavelength at which
the data need to be recorded for experimental phasing
(Garman &Murray, 2003). Although techniques such as sulfur
SAD (S-SAD) enable experimental phases to be calculated
from a ‘native crystal’, careful design of the diffraction
experiment is required to be able to exploit the very weak
anomalous differences, in addition to the difficulties in
collecting data at the long wavelengths needed (Basu et al.,
2019; Bent et al., 2016). Recent advances in both algorithms
and instrumentation, including long-wavelength beamlines
such as I23 at Diamond Light Source (Aurelius et al., 2017),
have rendered S-SAD an increasingly popular structure-
determination method.
In any case, where crystal growth or supply are difficult,
being able to determine the structure ‘natively’ can be parti-
cularly advantageous. Molecular replacement is also a
powerful way to identify ligands, whether these are potential
drugs, substrates or other compounds. After soaking or co-
crystallizing experiments using different ligands, data sets
recorded from multiple crystals of the same protein species in
different conditions are used for phase calculation in search of
a positive difference density representing a ligand in a
potential binding site (Krojer et al., 2017; Silvestri et al., 2018).
Over the years, a number of different programs have been
developed, some of which involve a more hands-on approach
requiring suitable search models to be identified and prepared,
such as Phaser (McCoy et al., 2007, 2018) and MOLREP
(Vagin & Teplyakov, 2010). Other programs such as AMPLE
and MrBUMP provide a more complete pipeline, requiring
only scaled reflections, the target sequence and, in the latter
case, a small number of fragments provided by another server,
Rosetta (Bibby et al., 2012; Rigden et al., 2008). Another
approach is to use BALBES, a fully automated pipeline that
uses a reorganized protein structure database derived from
the PDB in order to include multimeric and domain organi-
zation models (Long et al., 2008). Although these and other
MR pipelines are available in different software packages such
as CCP4i2 (Potterton et al., 2018) and Phenix (Liebschner et
al., 2019), here we focus on CCP4i2.
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Figure 1
MR pipelines. Overall schematic of molecular-replacement pipelines and the currently available and frequently used programs. A particular focus is
given to the pipelines and programs available within the CCP4i2 suite.
More recently, it has increasingly become possible to
determine phases using methods that do not use structural
homologues of the full protein or domains. ARCIMBOLDO
uses a fragment-based method and harnesses the predicted
secondary structure of the target sequence to place fragments
as search models (Milla´n et al., 2015), in combination with
powerful density-modification algorithms such as those
implemented in SHELXE (Sheldrick, 2010), to provide an
initial trace model (Uso´n & Sheldrick, 2018). This ab initio
method was initially developed and based on the presence of
-helical structures in the target structure and reflections in
the X-ray data that extend to approximately 2 A˚ resolution.
More recent versions of ARCIMBOLDO now include the
determination of -strand structures (Fedosyuk et al., 2016;
Sammito et al., 2013) and have also proven successful in
solving the phase problem for data to 2.6 A˚ resolution.
The working example described here is the PilA1 protein
from C. difficile. PilA1 is the major pilin of the type IV pili
(TFP) system in this clinically important Gram-positive
bacterium (Maldarelli, Matz et al., 2016). C. difficile is an
opportunistic pathogen, particularly affecting individuals with
a compromised gut microbiome, often owing to treatment with
antibiotics (Huang et al., 2009). Pili are long, proteinaceous
filaments which protrude from the surface of bacteria. They
are virulence factors which enable host colonization, either by
mediating interactions with host tissue, enabling direct binding
of the bacteria to the host and/or by mediating inter-bacterial
interactions, enabling bacterial aggregation/biofilm formation
(Manetti et al., 2007). TFP are the most widespread type of
pili, and are uniquely found in both Gram-positive and Gram-
negative species (Melville & Craig, 2013). In C. difficile and
related Clostridia, they have been implicated in twitching
ability and biofilm formation, both of which are important
pathogenicity factors (Maldarelli, Piepenbrink et al., 2016;
McKee et al., 2018). C. difficile has two TFP gene clusters, with
the primary cluster encoding all of the proteins required for
functional pili: the major pilin PilA1; the pre-pilin peptidase
PilD; the membrane-associated proteins PilC, PilMN and
PilO; the assembly and disassembly ATPases PilB and PilT;
and PilU, PilV and PilK, which are known as minor pilins.
PilA1 is thought to assemble into long pili filaments, which are
decorated by the minor pilins. Pilin proteins can be identified
by a highly conserved signal-peptide sequence (Imam et al.,
2011) that is cleaved by the pre-pilin peptidase PilD before
insertion into the pilin filament (Melville & Craig, 2013).
There are around 20 protein crystal structures of pilin
proteins in the PDB, mostly from Pseudomonas aeruginosa
(PDB entry 1qve; Audette et al., 2004), Neisseria gonorrhoeae
(PDB entry 2hi2; Craig et al., 2006) and N. meningitis (PDB
entry 2opd; Helaine et al., 2007). Pilins exhibit a long
N-terminal -helix (1) that forms a polymerization stalk
domain, and a globular C-terminal domain, described as the
headgroup, that consists of an – region linking the 1 helix
to a -sheet of at least three strands (Fig. 2; Craig & Li, 2008).
A highly variable region, known as the D-region, is located at
the C-terminus of the headgroup; it is predicted to be the most
solvent-accessible element and can form interactions with
host-cell surfaces (Craig & Li, 2008). The D-region is also
delimited by a disulfide bridge in the TFP pilin structures from
Gram-negative bacteria determined to date (Craig & Li,
2008).
Our attempts to determine the structure of a PilA1
construct lacking part of the N-terminal 1 helix to prevent
self-polymerization are used here as an example of molecular-
replacement approaches.
2. Methods
2.1. Recombinant protein production and purification
A PilA1 construct from C. difficile strain R20291 lacking the
first 34 amino acids (PilA11–34, corresponding to 139 of 173
residues) was donated by Edward Couchman (N. Fairweather
group, Imperial College London, England). CD3355 from
R20291 genomic DNA was amplified and inserted into an
empty pET-28a vector such that it was expressed with a non-
cleavable N-terminal 6His tag. PilA11–34 was expressed in
Escherichia coli Rosetta cells by inoculating 1 l Luria–Bertani
(LB) medium supplemented with 50 mg ml1 kanamycin and
30 mg ml1 chloramphenicol with 10 ml of an overnight
culture (100 ml LB with the same antibiotics). The cells were
grown at 37C until an optical density at 600 nm of 0.4–0.6 was
reached, at which point cultures were induced with isopropyl
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Figure 2
Structural features of TFP pilins. The crystal structure of full-length PilE1
from N. gonorrhoeae (PDB entry 2hi2; Craig et al., 2006) showcasing the
distinct domains of TFP pilin proteins: an N-terminal hydrophobic helix
(1) responsible for pilin polymerization, an – loop and a D-region. In
PilE1 and other TFP pilin structures from Gram-negative bacteria
determined to date, the D-region is delimited by a disulfide bond that
links the termini of the D-region (Cys121–Cys151 in this case; yellow).
This domain exhibits the lowest level of sequence conservation across
TFP pilins and contains a hypervariable loop with the highest level of
variability.
-d-1-thiogalactopyranoside at a final concentration of 1 mM.
Protein production was carried out at 20C with agitation at
180 rev min1 in an incubator for 20 h. The cells were
harvested by centrifugation at 3036g for 30 min, resuspended
in 20 mM Tris–HCl pH 8.0, 500 mM NaCl, centrifuged at
3011g for a further 10 min and the supernatant was discarded.
The cell extracts were purified by nickel-affinity purification
on a 5 ml HisTrap column (GE Healthcare) pre-equilibrated
with 50 mM Tris–HCl pH 8.0, 500 mM NaCl. His-tagged
protein was collected in 2 ml fractions during elution with 50,
125, 250, 375 and 500 mM imidazole in five steps of 15 ml.
Peak fractions were analyzed by SDS–PAGE, pooled and the
volume was reduced to 2 ml using a 3 kDa molecular-weight
cutoff concentrator (Amicon). The sample was loaded onto a
Superdex 75 16/600 size-exclusion column (GE Healthcare)
pre-equilibrated with 20 mM Tris–HCl pH 8.0, 150 mM NaCl
and connected to an A¨KTA pure FPLC system (GE Health-
care). Peak-containing fractions were analyzed by SDS–PAGE
and those containing pure protein were pooled and concen-
trated to 16 mg ml1 for use in crystallization trials.
2.2. Crystallization
Sitting drops of PilA11–34 were dispensed in 1:1 and 2:1
protein:crystallization solution ratios in MRC crystallization
plates with a Mosquito dispensing robot (TTP Labtech) using
several commercial crystallization screens. Crystals measuring
150  150  100 mm were obtained after four days of incu-
bation at 20C in 1.6M sodium citrate pH 6.5, a condition that
provides cryoprotection (Bujacz et al., 2010). Crystals were
harvested in nylon loops and directly flash-cooled in liquid
nitrogen for subsequent synchrotron data collection (Garman
& Owen, 2006).
2.3. X-ray diffraction data collection
Data sets were collected from four independent native
crystals on the fixed-wavelength ( = 0.92 A˚) beamline I04-1
at Diamond Light Source using a Dectris PILATUS 2M pixel-
array detector. Test images of each crystal at 0 and 90 were
recorded and iMosflm (Battye et al., 2011) was used to index
the data and determine the likely Bravais lattice and unit-cell
parameters of the crystal. The strategy function of iMosflm
was utilized to determine the optimum starting position of the
crystal for full, complete native data-set collection. The test
images also informed the detector distance settings by visual
assessment of the maximum resolution of spots on the test
images. The detector distance was set so that the resolution at
the edge of the detector was 1.5 A˚. During the diffraction
experiment, the crystal was rotated 200 with an exposure time
of 0.5 s and each image was recorded over an oscillation of
0.1. Such a strategy enabled the collection of a native data set
with high multiplicity and completeness in order to simplify
the structure-solution pipeline (Table 1).
2.4. X-ray diffraction data processing
Data were indexed and integrated using DIALS (Gildea et
al., 2014), which automatically selected space group P41212. It
should be noted that this is related to space group P43212, its
enantiomer, by an inversion at the origin (Shmueli, 2010) and
this ambiguity cannot be resolved at this stage. The data were
then imported into a CCP4 project using the CCP4i2 GUI
(Potterton et al., 2018) before scaling using AIMLESS (Evans
et al., 2011) (Table 1). The resolution cutoff was determined by
examining the CC1/2 and the I/(I) in the outer shell to a
resolution where the CC1/2 was 0.4 (Karplus & Diederichs,
2015), combined with an I/(I) of over 0.5 (Evans &
Murshudov, 2013). Assessment of the probabilities of the
space-group selection based on systematic absences as calcu-
lated by POINTLESS (Evans, 2006), performed as part of the
AIMLESS pipeline, did not solve the space-group ambiguity.
For both P43212 and P41212 the probability based on
systematic absences was 0.864, and therefore only solving the
phase problem and assessing the resulting electron-density
maps will enable the identification of the correct space group.
Systematic absences allow discrimination between possibilities
within a Laue group, but do not allow the distinction of
different enantiomers.
2.5. Structure determination, model building and validation
Molecular replacement was carried out within CCP4i2
(Potterton et al., 2018) using Phaser (McCoy et al., 2018) after
manual model preparation using Sculptor (Bunko´czi & Read,
2011) and Coot (Emsley et al., 2010). Ab initio MR with
ARCIMBOLDO_LITE (Milla´n et al., 2015) provided a
correct solution, from which a model was built using
Buccaneer (Cowtan, 2006). After iterative cycles of model
building and refinement with Coot (Emsley et al., 2010) and
REFMAC (Murshudov et al., 2011), the model was validated
using MolProbity (Williams et al., 2018). Details of these
processes are described below and refinement statistics are
given in Table 2.
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Table 1
Data-processing statistics for PilA1.
Values in parentheses are for the outer shell.
X-ray source Beamline I04-1, Diamond Light Source
Wavelength (A˚) 0.92
Resolution range (A˚) 51.21–1.65
Unit-cell parameters
a = b, c (A˚) 102.57, 104.34
 =  =  () 90
Space group P41212 or P43212
Total No. of reflections 964312 (39779)
No. of unique reflections 67404 (3396)
hI/(I)i 12.0 (0.6)
CC1/2 0.999 (0.390)
Rmeas 0.142 (3.961) [0.05†]
Multiplicity 14.3 (11.7)
Completeness (%) 100.0 (100.0)
Mosaicity () 0.12
Wilson B factor (A˚2) 27.1
† Low-resolution shell.
3. A manual approach
Here, we outline a simple manual approach to molecular
replacement (Fig. 1) as initially attempted to determine the
structure of PilA1.
3.1. Search for homologues
Identifying structural models of sequence-related proteins
for use as search models is the first step in the molecular-
replacement process. Published structures are stored in the
Protein Data Bank (PDB), and here we utilize the European
instance of the database, PDBe (https://www.ebi.ac.uk/pdbe/;
Armstrong et al., 2020). PDBe provides two methods to
perform a search of the PDB: by peptide sequence, a simple
FASTA sequence search and the more sophisticated PHMMER
approach (http://hmmer.org). Other tools such as HHpred
(Zimmermann et al., 2018), available as part of the MPI
Bioinformatics Toolkit (https://toolkit.tuebingen.mpg.de/), can
also be particularly powerful for identifying subunits within a
target sequence for which there are known structures.
In these searches, the full-length sequence of PilA1 was
used as the search query to ensure the greatest coverage.
Using the PHMMER approach at PDBe, a number of struc-
tural models were identified with a sequence identity of up to
43% that could be used as search models. The full-length
sequence of PilA1 was also submitted to the HHpred server
and a number of fragments for which there are known struc-
tures were identified which covered the PilA1 sequence to
varying degrees. Additionally, consideration should be made
of structures identified during a literature search. While their
sequence identity might be low, two proteins may display a
greater structural identity and such examples could help to
assemble a useful search model. In the case of PilA1, this is
particularly stark as pilins, which are also highly related to
pseudopilins (Melville & Craig, 2013), contain common
structural motifs including a lengthy N-terminal -helix and a
globular region (Fig. 2). Using this knowledge of pilins and
their common structural features allowed us to identify other
potential search models within known pilin and pseudopilin
structures, despite low sequence identity. This is a good
example of a situation in which applying prior information on
the biological properties of the protein of interest increases
the pool of structures available to build a good-quality search
model that may not show sequence identity above standard
thresholds.
The results from both the PHMMER and HHpred searches
were collated and assessed for their suitability. A summary of
the models identified and their corresponding sequence
identity to PilA1 are summarized in Table 3. A subset of these
results with higher similarity were chosen as initial search
models; these included PDB entries 4ixj and 2opd. PDB entry
4ixj represents a minor pilin from C. difficile (Piepenbrink et
al., 2014), PilJ, which has 20% identity to the PilA1 sequence.
PDB entry 2opd is a pilin from N. meningitidis (Helaine et al.,
2007) that displays 38% sequence identity to the PilA1
sequence.
3.2. Model preparation
A selection of tools for molecular-replacement model
preparation are available in CCP4i2. These include CCP4mg
and Coot (McNicholas et al., 2011; Emsley et al., 2010) for
selecting the components of a search model and directly
outputting them to a molecular-replacement process, while
CHAINSAW is used for mutating and truncating a search
model using sequence alignment with the target sequence
(Stein, 2008). In this case, Sculptor was the chosen tool and is
outlined in more detail in Bunko´czi & Read (2011).
The models identified during the search for homologues
were downloaded from PDBe in PDB format. They were
opened in Coot and chain A of each model was selected and
saved in PDB format; this ensured that the file only contained
chain A and no additional molecules such as waters or ligands.
Within CCP4i2, a similar strategy of selecting only protein
atoms from a specific chain is also available. The file produced
in Coot was then imported into Sculptor in CCP4i2, a tool that
can aid the success of molecular replacement by editing the
model based on sequence similarity, mutating and/or removing
unreliable regions (Bunko´czi & Read, 2011). To run Sculptor
on a model structure, both the search model (search PDB) and
a peptide-sequence alignment of the target and search
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Table 2
Refinement statistics for PilA1.
Ramachandran statistics and MolProbity clashscore were obtained using
MolProbity (Williams et al., 2018).
Space group P41212
Rwork (%) 19.4
Rfree (%) 21.4
No. of non-H atoms
Protein 3069
Solvent 254
No. of residues 400
R.m.s. deviations
Bond angles () 1.30
Bond lengths (A˚) 0.01
Average B factor (A˚2)
Overall 28.00
Protein 28.53
Water 34.38
Ramachandran plot
Most favoured regions (%) 97.21
Allowed regions (%) 2.57
Outliers (%) 0
Clashscore 0.48
MolProbity clashscore 0.81
Table 3
Related homologues used to build the search ensemble and methods of
identification.
Protein, organism
PDB
code
Sequence
identity (%) Method of identification
PilX, Neisseria meningitidis 2opd 38.46 PDBe BLAST, HHPred
Pseudopilin, Escherichia coli 3g20 28.30 PDBe BLAST, HHPred
PulG, Klebsiella pneumoniae 1t92 27.18 PDBe BLAST, HHPred
PilJ, Clostridioides difficile 4ixj 19.86 PDBe BLAST, HHPred
PilE, Francisella tularensis 3soj 14.42 Literature review
PilA, Acinetobacter baumannii 5vaw 13.49 Literature review
FimU, Pseudomonas aeruginosa 4ipu 13.51 HHPred
proteins must be provided. A suitable alignment can be
performed using ClustalW (Larkin et al., 2007), which is
available in the CCP4i2 suite as part of the model-preparation
tab of the tasks menu. The target and related sequences are
inputted in FASTA format and an alignment file (in ALN
format) is generated, which is then available within the
CCP4i2 Sculptor input form. The search model output by
Sculptor is now ready for use in a molecular-replacement
process.
To create ensembles containing multiple structures, search
models edited to contain a single chain were loaded into Coot
and aligned using the secondary-structure matching tool
(SSM). The coordinates of the aligned structures were then
saved in PDB format. These edited search models were then
input into the ensemble builder for Phaser in CCP4i2. The
peptide sequences of these models were aligned as described
previously and were also added to the input form.
3.3. Molecular replacement
Here, we will focus on Phaser (McCoy et al., 2007) as the
main tool for MR within CCP4i2. The input parameters for
basic MR using Phaser require a reflection file, information
about the composition of the asymmetric unit and a search
model. In CCP4i2, the reflection file is selected from the
output from AIMLESS. The composition of the asymmetric
unit is determined by inputting the sequence of the target
protein; a job is then run to calculate the Matthews coefficient,
which allows an estimation of the likely number of molecules
in the asymmetric unit. In the case of PilA1, the Matthews
coefficient was ambiguous between either three or four
possible copies in the asymmetric unit. Finally, the search
model, provided as a PDB file containing either a single search
model or an ensemble of search models, is selected. In this
section, Phaser can also be given information regarding the
similarity of the search models to the target protein either as a
sequence-identity score or a root-mean-squared (r.m.s.) value,
indicating the expected deviation between the target and
search structures (Supplementary Fig. S1).
At the end of the process, Phaser provides two key scores
that must be assessed to determine whether a correct solution
with phases that allow the calculation of an interpretable
electron-density map has been obtained: the TFZ score and
the LLG. A TFZ (translation-function Z-score) value above 8
indicates that the solution has definitely been found, while a
score of 7 or lower suggests that it is increasingly less likely
that a correct solution has been obtained. During the Phaser
process, the LLG is also a good indicator of whether the
solution is correct, and this value should increase greatly as a
correct solution is found (usually to greater than 100). Both of
these values are displayed in the Phaser job window in CCP4i2
as the job runs and can be found in the results window once
the process has completed (Supplementary Fig. S2). In the
case of PilA1 using our ensemble, these values are a TFZ of
5.7 and a final LLG of 29, indicating that this was not a correct
solution. When viewed in Coot the map was discontinuous,
also confirming that the phase problem had not been solved.
Owing to the space-group ambiguity, the search was carried
out in Phaser selecting all possible enantiomorphs. The
selected solution was in space group P43212, the enantiomorph
of P41212, but the TFZ scores for other possibilities were
similarly low. In any case, this is an ambiguity that would only
be clearly resolved if the phase problem had been correctly
solved.
Unfortunately, in the case of PilA1, we have not successfully
found a solution using this method of MR. However, this is a
useful approach to use, especially if more similar structural
homologues are available. Fortunately, other methods are
available which utilize MR without the need to collect any
further diffraction data, such as experimental phasing data.
3.4. Ab initio MR
Molecular replacement without search models is becoming
ever more possible on a desktop computer, using programs
such as AMPLE and ARCIMBOLDO. ARCIMBOLDO uses
a fragment-based approach, placing short fragments from
secondary-structure predictions to determine the initial phases
(Milla´n et al., 2015). ARCIMBOLDO uses Phaser to place
these fragments before density modification using SHELXE
(Sheldrick, 2010). PilA1 is a promising candidate for
ARCIMBOLDO, with the full-length PilA1 predicted to
contain an extended N-terminal -helix of approximately 60
residues and the diffraction data collected to a resolution of
greater than 2 A˚.
Tools such as PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/)
and JPred (http://www.compbio.dundee.ac.uk/jpred/) allow
secondary-structure predictions when provided with a peptide
sequence (Buchan & Jones, 2019; Jones, 1999; Drozdetskiy et
al., 2015). The output of a PSIPRED analysis of the truncated
construct of PilA1 used here predicts a 30-residue-long
-helix, as expected based on our knowledge of TFP pilins.
TheARCIMBOLDO_LITE distribution can now be used on a
single multi-core machine and is distributed with CCP4i2. The
information required to run a job includes scaled reflection
data (MTZ format), the molecular mass of the target protein
and the number of copies in the asymmetric unit. As the PilA1
crystals are calculated to contain either three or four copies
in the asymmetric unit, two separate processes were run
searching for three or four copies of an -helix containing 30
residues.
In the case of PilA1, after approximately 20 h of run time on
a modest desktop machine, ARCIMBOLDO_LITE was able
to provide a solution. An electron-density map, a PDB file of
the backbone of the best solution and an HTML-based report
were output (Fig. 3a). In line with the SHELX package, the
success of the process is assessed using a correlation coeffi-
cient (CC). A correct solution is likely to have been found
when the CC is greater than 25% (Uso´n & Sheldrick, 2018).
The final CC for the PilA1 process is 42.3%, indicating that a
correct solution has been determined (Fig. 1a). Additionally,
378 out of 432 residues were built, including the key structural
features of TFP (details in Fig. 2): one N-terminal -helix from
each molecule (each of approximately 30 residues), as well as
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the -sheet characteristic of the head domain. On inspection
of the electron-density map, good continuity is observed, a
further indication that the phases had been correctly calcu-
lated and a solution had been found (Fig. 3b).
In the case of PilA1, ab initio MR methods were successful
in solving the phase problem, rather than using a search model
that was based on sequence homology. As such, the output of
ARCIMBOLDO was used for model building and refinement.
3.5. Model building, refinement
and validation
Two model-building tools are
provided in CCP4i2: ARP/wARP
(Chojnowski et al., 2019) and
Buccaneer (Cowtan, 2006). For
the purposes of this workflow, we
used Buccaneer to build upon the
polyalanine model that was
generated by ARCIMBOLDO.
Buccaneer has two input modes in
CCP4i2 that are tailored to phase
problems that have been solved
using experimental phasing or
using molecular replacement. For
PilA1, we selected the molecular-
replacement mode and therefore
we must input the search model
that was used for structure
determination. In this case, we
can input the polyalanine model
generated by ARCIMBOLDO_
LITE. We must also input the
scaled reflections and the free R
set that were generated by
AIMLESS. Finally, we must
define the crystal contents by
inputting the target sequence.
These are the only essential
pieces of information that
Buccaneer requires to run the
process, but a large number of
more advanced parameters can
also be input. For the case of
PilA1, the default values were
used. After model building,
Buccaneer also utilizes REFMAC
(Murshudov et al., 2011) to
perform an initial round of
refinement. As well as visually
inspecting the resulting output, it
is also important to note the
statistics of the completed job,
including the number of residues
that have been built as well as the
refinement measures Rwork and
Rfree. These initial refinement
statistics may be high (0.5) but will decrease with further
rounds of refinement, which involves iterative cycles of auto-
mated refinement using REFMAC (Murshudov et al., 2011),
followed by inspection and manual adjustment in Coot. As the
resolution of the PilA11–34 data (1.65 A˚) is borderline for
the use of anisotropic B factors in refinement (Merritt, 2012),
an isotropic refinement protocol was used throughout. Coot
was used to refine local bond angles, check the sequence
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Figure 3
Ab initioMRwithARCIMBOLDO_LITE. (a) HTML-basedARCIMBOLDO_LITE output, showing that
three 30-residue -helical fragments have been found and the corresponding statistics. The overall
correlation coefficient (CC) was 43.2%, as highlighted, and 378 residues have been traced. (b) Electron-
density map (blue chicken wire) at a 1.5 contour level showing that well defined density and clearly
identifiable side chains were obtained. The traced residues are built as polyalanine chains (stick
representation) in ARCIMBOLDO_LITE, which fitted well into the electron-density map.
register with the electron density, add alternate side-chain
conformations and add water molecules. After several rounds
of refinement, Rwork and Rfree values of 19.4% and 21.4%,
respectively, were achieved (Bru¨nger, 1992, 1993).
Structure validation was performed using MolProbity
(Williams et al., 2018). This software also identified and flipped
any aspartate, glutamate or histidine residues that clashed and
added riding hydrogens so that hydrogen-bonding potential
can be assessed (Chen et al., 2010). Clashing side chains,
unfavoured rotamers and Ramachandran outliers were iden-
tified by MolProbity and problematic residues were inspected
and manually fixed using Coot whenever the electron-density
maps failed to support the unusual conformations. After a
further round of REFMAC refinement and assessment in
MolProbity, it was noted that there were still a number of
bond lengths and angles with root-mean-squared deviations
(r.m.s.d.s) outside the acceptable ranges (Rossmann &
Arnold, 2001). A weighting term was applied in REFMAC,
also under restraints in the input form, starting at 0.1 and
incremented in steps of 0.5. The output of these was assessed
in MolProbity until there were no outliers unless justified by
the electron-density maps and the Rwork and Rfree values were
closely observed to ensure that there was no bias occurring
from the weighting. A final weighting term of 0.1 was chosen.
Final CIF files were prepared using the CCP4i2 interface
under the deposition section of the task menu for analysis
using the PDBe validation server (https://validate-pdbe.
wwpdb.org/). Once validated, the files were uploaded to the
PDBe deposition server (https://deposit-pdbe.wwpdb.org/)
with PDB identifier 6t8s.
4. PilA1 structure
The structure of R20291 PilA11–34 (Fig. 4) is typical of the
TFP pilins, containing a long N-terminal -helix (1) which is
linked by an – loop to an antiparallel -sheet (1–2–3)
that encapsulates the D-region containing a shorter -helix
(2), with the rest of this subdomain largely formed of loop
regions. As there are no cysteine residues in PilA1, it lacks the
disulfide bridge that delimits the D-region of Gram-negative
pilins.
The crystal structures of PilA1 from R20291 and two other
strains were published in 2015, and although these structures
included a maltose-binding protein (MBP) tag, the structure
of the R20291 PilA1 monomer was essentially the same
(Piepenbrink et al., 2015). The core r.m.s.d. between our model
and the published structure, as calculated using the secondary-
structure matching tool in Coot, was 0.89 A˚. However,
Piepenbrink and coworkers
determined the structures of
MBP-PilA1 fusions, while the
structure described here contains
a much shorter 6His tag,
allowing us to observe PilA1
multimers which provide possible
PilA1 interfaces. There are three
molecules in the asymmetric unit
and interactions within this
arrangement could be biologi-
cally relevant for pilus formation,
so the coordinates were
submitted to the Protein Inter-
faces, Surfaces and Assemblies
(PISA) server (Krissinel &
Henrick, 2007) for investigation.
PISA scores interfaces between
molecules using a complex-
formation significance score
(CSS), and is used to assess
whether molecular interfaces are
biologically significant or a
product of crystallization: 0.0
indicates no biological signifi-
cance and a value of 1.0 indicates
significant complex formation
(Krissinel & Henrick, 2007). A
summary of the interfaces
detected by PISA is presented in
Supplementary Table S1. Of
particular interest was a salt
bridge between Asp62 and Lys96
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Figure 4
R20291 PilA1 structure. (a) Chain A of R20291 PilA11–34 (cartoon) contains the structural regions
associated with TFP pilin structures: a long 1 helix (dark blue) followed by an – loop that connects the
long -helix and an antiparallel -sheet (green). The variable D-region (cyan) contains a shorter -helix of
ten residues in length, but is mostly composed of flexible loops. (b) Top view of the three molecules
observed in the asymmetric unit of R20291 PilA11–34, showing potential pilin–pilin interfaces. (c)
Analysis using PISA indicated a possible interface between R20291 PilA11–34 molecules via an Asp62–
Lys96 salt bridge.
in neighbouring R20291 PilA11–34 molecules (Fig. 4), part
of an interface with a calculated surface area representing 7%
of the solvent-accessible area of the pilin. A number of
hydrogen-bonding interactions were also predicted to contri-
bute to this interface, indicating that it could be biologically
relevant. Moreover, attempts to mutate either residue to
alanine resulted in insoluble or no recombinant protein being
produced, suggesting that these residues are important for
protein stability. Interestingly, this interaction had not been
observed in the published structural models (Piepenbrink et
al., 2014, 2015) as the presence of the large MBP tag prevented
any direct PilA1–PilA1 interactions. Instead, the authors of
these studies suggested that a different interaction would be
relevant for TFP filament formation based on the models of
filament formation proposed for the TFP filaments from
N. meningitidis, N. gonorrhoeae and Vibrio cholerae (Hartung
et al., 2011; Craig & Li, 2008; Craig et al., 2003, 2006). These
models were built using crystallographic and NMR structures
of the pilin proteins and electron-microscopy data of the full
filament structure to fit the pilin units (Craig & Li, 2008). Such
models place the extended, hydrophobic N-terminal -helix
within the core of the filament, interacting with other pilin
units via hydrophobic interactions. Based on the similarities
between PilA1 and these structures, Piepenbrink et al. (2015)
proposed a model for TFP filament formation in C. difficile in
which a salt bridge between PilA1 units via Lys30 and Glu75
would be equivalent to that observed in the TcpA filament
model. However, this salt bridge is not observed in our direct
PilA1–PilA1 interactions.
As part of our analysis of the PilA1 structure, we submitted
our model to the PDBeFold (Krissinel & Henrick, 2004) and
DALI (Holm & Rosenstro¨m, 2010) servers to identify similar
structures in the PDB. This search readily retrieved structures
of several TFP pilins, such as the full-length PilE1 (PDB entry
2hi2) from N. gonorrhoeae (Craig et al., 2006) that shared 39%
sequence identity with the C. difficile protein. It also retrieved
the structures of the major pilins from other Gram-positive
bacteria such as TcpA from V. cholerae (PDB entries 1oqv
and 3hrv; Craig et al., 2003; Lim et al., 2010), CofA from E. coli
(PDB entry 3s0t; Kolappan et al., 2012) and PilS from
Salmonella typhi (PDB entry 3fhu; Balakrishna et al., 2009).
Interestingly, the structures of type II secretion system (TIISS)
pseudopilins from Gram-negative bacteria were also
retrieved, such as PulG (PDB entry 1t92) from Klebsiella
pneumoniae (Ko¨hler et al., 2004), EspG from V. cholerae
(PDB entry 4lw9; F. S. Vago, K. Raghunathan, J. C. Jens, W. J.
Wedemeyer, M. Bagdasarian, J. S. Brunzelle & D. N. Arvidson,
unpublished work) and GspG from E. coli (PDB entry 3g20;
Korotkov et al., 2009). Pseudopilins are part of the TIISS, are
similar in architecture to TFP and export pilin-like units;
however, they do not readily form filaments as observed in
TFP (Korotkov et al., 2012). All structures share the commonly
observed fold of TFP, including the N-terminal -helix (1)
connected to the head domain and the variable D-region at
the C-termini (Fig. 2). Whether Gram-positive TFP pilins are
functionally more similar to the TIISS pseudopilins or the
Gram-negative pilins remains to be determined once full-
length pilin and filament structures have been determined. It
will therefore be important to determine the structures of the
full-length PilA1 and other minor pilins, as well as investigate
the interactions between these proteins, to elucidate pili fila-
ment formation. Together, this information would allow us to
start unravelling the mechanisms underlying TFP formation
and assembly in C. difficile.
5. Conclusion
Despite collecting high-resolution data for R20291 PilA11–
34, it was not possible to calculate phases and an interpretable
electron-density map using our manually edited search models
based on known pilin structures. As the native data set for
R20291 PilA11–34 had high resolution (1.65 A˚), high
completeness, low Rmeas and high I/(I), it was an ideal
candidate for ab initio phasing using ARCIMBOLDO (Milla´n
et al., 2015). As our example shows, using a careful approach
to molecular-replacement pipelines and exploring available
options, combined with prior knowledge of both the biology
and structural characteristics of the protein of interest, can
lead to solution of the phase problem and the determination
of novel protein structures.
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